Campaign India Team
Jun 17, 2018

Cannes Lions 2018: DDB Mudra, Grey, McCann and TBWA get three shortlists each in Health, Pharma Lions

JWT also in the running with one shortlist

Cannes Lions 2018: DDB Mudra, Grey, McCann and TBWA get three shortlists each in Health, Pharma Lions
The organisers of the Cannes Lions International Festival of Creativity have announced the shortlists for the Health and Wellness, Pharma Lions.
 
Thirteen Indian entries have made the cut.
 
DDB Mudra's 'Project free period' for Johnson & Johnson Stayfree Sanitary Pads has three of them.
 
Grey Group India has three shortlists for 'The health purse (sehat ka batua) for Mahindra Rise.
 
McCann Health New Delhi also has three shortlists, all for 'Noon Assembly' for Kwality Milk.
 
TBWA's three shortlists come in the Pharma Lions for 'Blind to Speak' for Asha Ek Hope Foundation.
 
J Walter Thompson has one shortlist for 'Every Half Counts' for UNICEF.
 
 
 
Source:
Campaign India

Follow us

Top news, insights and analysis every weekday

Sign up for Campaign Bulletins

Related Articles

Just Published

Premium
Abhishek Chaswal joins McCann Delhi as ECD
Premium
Weekend Laugh: Producer's Diary by Dalbir Singh
Premium
2 days ago

Weekend Laugh: Producer's Diary by Dalbir Singh

The co-founder of Kiss Films continues with his weekly sketches for Campaign India

Premium
McCann Health terminates global CCO following employee complaint
Premium
2 days ago

McCann Health terminates global CCO following ...

Jeremy Perrott violated the agency's code of conduct. This marks the second termination of a prominent global industry figure this week based on employee complaints, following Ogilvy's firing of Tham Khai Meng.

Premium
Deja Vu: Thai Kham Meng and life after Cannes
Premium
3 days ago

Deja Vu: Thai Kham Meng and life after Cannes

Barely a week ago, this guest author had applauded the gender inclusive stance of Thai Kham Meng, Ogilvy's worldwide creative chief who was fired yesterday for reasons that are currently under wraps. Do Indian companies have a similar zero-tolerance policy when it comes to senior executives?